Patents by Inventor Steven David Gardner

Steven David Gardner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240390609
    Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.
    Type: Application
    Filed: June 12, 2024
    Publication date: November 28, 2024
    Applicant: Norton (Waterford) Limited
    Inventors: Enrique Calderon Oliveras, Daniel Buck, Erica Jamie Kantor, Ross William Weir, James Roche, Steven David Gardner, Robert Owen Kivlin
  • Publication number: 20210220579
    Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.
    Type: Application
    Filed: April 6, 2021
    Publication date: July 22, 2021
    Applicant: Norton (Waterford) Limited
    Inventors: Enrique Calderon Oliveras, Daniel Buck, Erica Jamie Kantor, Ross William Weir, James Roche, Steven David Gardner, Robert Owen Kivlin
  • Patent number: 11000653
    Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: May 11, 2021
    Assignee: Norton (Waterford) Limited
    Inventors: Enrique Calderon Oliveras, Daniel Buck, Erica Jamie Kantor, Ross William Weir, James Roche, Steven David Gardner, Robert Owen Kivlin
  • Patent number: 10839669
    Abstract: In some embodiments, a method includes producing, from an adapter, a first wireless signal characterized by a first communication mode with a computing device when a portion of at least one of a medicament delivery device or a simulated medicament delivery is disposed within the adapter. An indication is received when the portion of the medicament delivery device or the simulated medicament delivery device is removed from the adapter. A second wireless signal characterized by a second communication mode with the computing device is produced in response to the indication. The second communication mode is different from the first communication mode. The second communication mode can be, for example, a hold mode, a sniff mode or a park mode.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: November 17, 2020
    Assignee: kaleo, Inc.
    Inventors: Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers, Vaishali Vilas Kamat, Steven David Gardner, Robert George Milner
  • Publication number: 20180151053
    Abstract: In some embodiments, a method includes producing, from an adapter, a first wireless signal characterized by a first communication mode with a computing device when a portion of at least one of a medicament delivery device or a simulated medicament delivery is disposed within the adapter. An indication is received when the portion of the medicament delivery device or the simulated medicament delivery device is removed from the adapter. A second wireless signal characterized by a second communication mode with the computing device is produced in response to the indication. The second communication mode is different from the first communication mode. The second communication mode can be, for example, a hold mode, a sniff mode or a park mode.
    Type: Application
    Filed: January 31, 2018
    Publication date: May 31, 2018
    Applicant: kaleo, Inc.
    Inventors: Eric S. EDWARDS, Evan T. EDWARDS, Mark J. LICATA, Paul F. MEYERS, Vaishali Vilas KAMAT, Steven David GARDNER, Robert George MILNER
  • Publication number: 20180140788
    Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.
    Type: Application
    Filed: September 14, 2017
    Publication date: May 24, 2018
    Applicant: Norton (Waterford) Limited
    Inventors: Enrique Calderon Oliveras, Daniel Buck, Erica Jamie Kantor, Ross William Weir, James Roche, Steven David Gardner, Robert Owen Kivlin
  • Patent number: 9911308
    Abstract: In some embodiments, a method includes producing, from an adapter, a first wireless signal characterized by a first communication mode with a computing device when a portion of at least one of a medicament delivery device or a simulated medicament delivery is disposed within the adapter. An indication is received when the portion of the medicament delivery device or the simulated medicament delivery device is removed from the adapter. A second wireless signal characterized by a second communication mode with the computing device is produced in response to the indication. The second communication mode is different from the first communication mode. The second communication mode can be, for example, a hold mode, a sniff mode or a park mode.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: March 6, 2018
    Assignee: kaleo, Inc.
    Inventors: Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers, Vaishali Vilas Kamat, Steven David Gardner, Robert George Milner
  • Publication number: 20170072160
    Abstract: In various arrangements, a nebulizer element of a nebulizer may be energized with a drive signal. A phase offset of the drive signal may be measured. A phase delta may be determined. The phase delta may indicate a difference between a target phase offset and the measured phase offset. The target phase offset may indicate a non-zero target phase difference between the voltage of the drive signal and the current of the drive signal. A frequency of the drive signal may be changed to decrease the phase delta.
    Type: Application
    Filed: November 23, 2016
    Publication date: March 16, 2017
    Applicant: Nektar Therapeutics
    Inventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
  • Patent number: 9533118
    Abstract: In various arrangements, a nebulizer element of a nebulizer may be energized with a drive signal. A phase offset of the drive signal may be measured. A phase delta may be determined. The phase delta may indicate a difference between a target phase offset and the measured phase offset. The target phase offset may indicate a non-zero target phase difference between the voltage of the drive signal and the current of the drive signal. A frequency of the drive signal may be changed to decrease the phase delta.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: January 3, 2017
    Assignee: Nektar Therapeutics
    Inventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
  • Publication number: 20160058958
    Abstract: Various methods, devices, and systems are described for aerosolizing a liquid. Embodiments may include sealing the liquid within a reservoir. An output waveform signal may be generated. A nebulizer element may be vibrated to aerosolize the liquid. A negative pressure may be produced within the reservoir as the liquid is aerosolized. The output waveform signal may cause the nebulizer element to vibrate. Embodiments may involve determining a phase shift between a current of the output waveform signal and a voltage of the output waveform signal. Also, embodiments may involve adjusting a frequency of the output waveform signal at least partially based on the phase shift. Further, embodiments may involve adjusting the voltage of the output waveform signal at least partially based on the frequency of the output waveform signal.
    Type: Application
    Filed: September 1, 2015
    Publication date: March 3, 2016
    Applicant: Nektar Therapeutics
    Inventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
  • Patent number: 9272101
    Abstract: Various arrangements for determining whether a liquid is in contact with a nebulizer element are disclosed. A nebulizer element may be energized with an electrical signal at a measurement frequency. An impedance of the nebulizer element may be measured, thereby obtaining a measured impedance value. The impedance value may be compared to a stored impedance value. Based on the comparison, it may be determined whether the liquid contacts the nebulizer element.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: March 1, 2016
    Assignee: NEKTAR THERAPEUTICS
    Inventors: Benjamin Morris Gordon, Steven David Gardner, Thomas Edward Parker
  • Patent number: 9149588
    Abstract: Various methods, devices, and systems are described for aerosolizing a liquid. Embodiments may include sealing the liquid within a reservoir. An output waveform signal may be generated. A nebulizer element may be vibrated to aerosolize the liquid. A negative pressure may be produced within the reservoir as the liquid is aerosolized. The output waveform signal may cause the nebulizer element to vibrate. Embodiments may involve determining a phase shift between a current of the output waveform signal and a voltage of the output waveform signal. Also, embodiments may involve adjusting a frequency of the output waveform signal at least partially based on the phase shift. Further, embodiments may involve adjusting the voltage of the output waveform signal at least partially based on the frequency of the output waveform signal.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: October 6, 2015
    Assignee: NEKTAR THERAPEUTICS
    Inventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
  • Publication number: 20140243749
    Abstract: In some embodiments, a method includes producing, from an adapter, a first wireless signal characterized by a first communication mode with a computing device when a portion of at least one of a medicament delivery device or a simulated medicament delivery is disposed within the adapter. An indication is received when the portion of the medicament delivery device or the simulated medicament delivery device is removed from the adapter. A second wireless signal characterized by a second communication mode with the computing device is produced in response to the indication. The second communication mode is different from the first communication mode. The second communication mode can be, for example, a hold mode, a sniff mode or a park mode.
    Type: Application
    Filed: December 27, 2013
    Publication date: August 28, 2014
    Applicant: INTELLIJECT, INC.
    Inventors: Eric S. EDWARDS, Evan T. EDWARDS, Mark J. LICATA, Paul F. MEYERS, Vaishali KAMAT, Steven David Gardner, Robert George Milner
  • Publication number: 20140007864
    Abstract: In various arrangements, a nebulizer element of a nebulizer may be energized with a drive signal. A phase offset of the drive signal may be measured. A phase delta may be determined. The phase delta may indicate a difference between a target phase offset and the measured phase offset. The target phase offset may indicate a non-zero target phase difference between the voltage of the drive signal and the current of the drive signal. A frequency of the drive signal may be changed to decrease the phase delta.
    Type: Application
    Filed: September 4, 2013
    Publication date: January 9, 2014
    Applicant: Nektar Therapeutics
    Inventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
  • Publication number: 20120291777
    Abstract: Various arrangements for determining whether a liquid is in contact with a nebulizer element are disclosed. A nebulizer element may be energized with an electrical signal at a measurement frequency. An impedance of the nebulizer element may be measured, thereby obtaining a measured impedance value. The impedance value may be compared to a stored impedance value. Based on the comparison, it may be determined whether the liquid contacts the nebulizer element.
    Type: Application
    Filed: January 19, 2011
    Publication date: November 22, 2012
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Benjamin Morris Gordon, Steven David Gardner, Thomas Edward Parker
  • Publication number: 20120111963
    Abstract: Various methods, devices, and systems are described for aerosolizing a liquid. Embodiments may include sealing the liquid within a reservoir. An output waveform signal may be generated. A nebulizer element may be vibrated to aerosolize the liquid. A negative pressure may be produced within the reservoir as the liquid is aerosolized. The output waveform signal may cause the nebulizer element to vibrate. Embodiments may involve determining a phase shift between a current of the output waveform signal and a voltage of the output waveform signal. Also, embodiments may involve adjusting a frequency of the output waveform signal at least partially based on the phase shift. Further, embodiments may involve adjusting the voltage of the output waveform signal at least partially based on the frequency of the output waveform signal.
    Type: Application
    Filed: July 19, 2010
    Publication date: May 10, 2012
    Applicant: Nektar Therapeutics
    Inventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
  • Patent number: D804437
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: December 5, 2017
    Assignee: Norton (Waterford) Limited
    Inventors: Erica Jamie Kantor, Steven David Gardner, Ross William Weir